Last reviewed · How we verify
NCT03525184
Nutrition Intervention to Promote Immune Recovery From Sleep Restriction
NA trial testing Additional protein and multi-nutrient beverage in Sleep Restriction in 20 participants. Completed in 10 December 2019.
10 December 2019
Quick facts
| Lead sponsor | United States Army Research Institute of Environmental Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 12 February 2018 |
| Primary completion | 10 December 2019 |
| Estimated completion | 10 December 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Additional protein and multi-nutrient beverage
- Placebo beverage — full drug profile →
Conditions studied
- Sleep Restriction — all drugs for Sleep Restriction →
Sponsor
United States Army Research Institute of Environmental Medicine
Who can join
Adults 18 to 45, any sex, with Sleep Restriction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical and psychological stress on Warfighters during training and operational missions can suppress immune responsiveness. Skin wound models can be used to detect changes in immune function. Investigators have recently demonstrated that relatively modest sleep disruption degrades immune response at the site of the disrupted skin barrier and delays the initial restoration of the skin barrier. Provision of additional protein and a multi-nutrient beverage during and after sleep restriction seems to mitigate decrements in local immune function, without producing detectable effects on initial restoration of the skin barrier. However, the prior work used a parallel-group study design and inter-subject variability may have made it more difficult to detect significant differences in skin barrier restoration between participants receiving the nutrition intervention versus those receiving the placebo. Therefore, the purpose of the proposed cross-over study is to test the efficacy of a multi-nutrient beverage and additional protein (1.5 g protein per kg body weight versus 0.9 g protein per kg body weight) on immune function and the initial restoration of the skin barrier consequent to an operational stressor (i.e., 72-h sleep restriction). The effect of sleep restriction on a friend-foe marksmanship task, flow state, and measures of cognitive and neuromotor performance, will be investigated as a sub-study (Appendix A). Additionally, the effects of sleep restriction on appetite physiology, eating behaviors and intestinal permeability will be tested. Research will be conducted in a laboratory environment using male and female Soldiers from the human research participant detachment (NSRDEC), or Soldiers or civilians at NSRDEC and/or USARIEM. Participants in the study described herein (n = 20) will be exposed, in a single-blind, cross-over design to a \~72 hour normal sleep control phase, and to 2 periods of \~72 hours of sleep restriction (monitored in laboratory with \~2-h sleep per night) during which time eight blisters will be induced via suction on participant's forearm and the top layer of blisters will be removed to reveal the dermal layer of skin. In the normal sleep trial, participants will consume \~0.9 g protein per kg body weight per day and a placebo beverage during (3 days). In the first sleep restriction trial, participants will consume \~0.9 g protein per kg body weight per day and a placebo beverage during (3 days) and after (5 days) sleep restriction; and, in the second sleep restriction trial (after at least two weeks wash-out) participants will instead consume \~1.5 g protein per kg body weight and a multi-nutrient beverage (arginine: 20 g·d-1, glutamine: 30 g·d-1, zinc sulfate: 24 mg·d-1, vitamin C: 400 mg·d-1, vitamin D3: 800 IU·d-1 and omega-3 fatty acids: 1 g·d-1). Outcome measures include immune function (e.g., circulating markers of inflammation, cytokines at the blister site, and secretory immunoglobin A), skin barrier restoration time (by transepidermal water loss), subjective appetite ratings, appetite-mediating hormone concentrations, food preferences and cravings, gut microbiota composition, and intestinal permeability. Findings from this study will determine if a nutritional intervention attenuates the loss of immune responsiveness to a military relevant stressor (i.e., sleep restriction), and will determine the effects of acute sleep restriction on appetite, gut microbiota composition, and intestinal permeability.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Severe, short-term sleep restriction reduces gut microbiota community richness but does not alter intestinal permeability in healthy young men.
Karl JP, Whitney CC, Wilson MA, Fagnant HS, et al · · 2023 · cited 18× · PMID 36604516 · DOI 10.1038/s41598-023-27463-0 -
Supplemental Protein and a Multinutrient Beverage Speed Wound Healing after Acute Sleep Restriction in Healthy Adults.
Smith TJ, Wilson M, Whitney C, Fagnant H, et al · · 2022 · cited 8× · PMID 35285906 · DOI 10.1093/jn/nxac064 -
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Verify or expand the search:
- PubMed search for NCT03525184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Restriction
Currently open trials in the same condition.
- NCT04037605 — Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women · EARLY_PHASE1 · active not recruiting
- NCT03377543 — Sleep and Inflammatory Resolution Pathway · EARLY_PHASE1 · active not recruiting
- NCT03142893 — Hormonal Mechanisms of Sleep Restriction - Axis Study · Phase 1 · active not recruiting
Other United States Army Research Institute of Environmental Medicine trials
Trials by the same sponsor.
- NCT07489690 — Energy Dense Fueling for Cold-Weather Operations · NA · recruiting
- NCT07099872 — Chronic Exercise With Overdressing · NA · completed
- NCT06468748 — The Effects of Semaglutide on Body Composition and Performance in Military Personnel · Phase 4 · withdrawn
- NCT07063173 — Bioavailability of Ration Items Containing Tart Cherry Extract · NA · recruiting
- NCT06073080 — Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03525184 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by United States Army Research Institute of Environmental Medicine
- Last refreshed: 27 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing